Literature DB >> 19757177

Differential expression of a novel gene BRE (TNFRSF1A modulator/BRCC45) in response to stress and biological signals.

John Yeuk-Hon Chan1, Li Li, Ji Miao, Dong-Qing Cai, Kenneth Ka-Ho Lee, Yiu-Loon Chui.   

Abstract

Stress-responsive genes play critical roles in many biological functions that includes apoptosis, survival, differentiation and regeneration. We have identified a novel stress-responsive gene called BRE which interacts with TNF-receptor-1 and blocks the apoptotic effect of TNF-alpha. BRE enhances tumor growth in vivo and is up-regulated in hepatocellular and esophageal carcinomas. BRE also regulates the ubiquitination of the DNA repair complex BRCC, and the synthesis of steroid hormones. Here, we examined BRE-mRNA in cells after treatments with UV and ionizing radiation (IR). UV and IR treatment alone suppressed BRE-mRNA levels by more than 90% at 24 h, while hydroxyurea, fluorodeoxyuridine, aphidicolin, known inhibitors of S-phase DNA synthesis, had no significant effect. BRE protein expression was unaltered in cells treated with TNF-alpha, Interleukin-1 and Dexamethasone, while a threefold increase was observed following chorionic gonadotropin exposure. Although BRE plays a regulatory role in many different pathways, yet its expression is apparently under very stringent control.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19757177     DOI: 10.1007/s11033-009-9796-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

Authors:  Yuanshu Dong; Mohamed-Ali Hakimi; Xiaowei Chen; Easwari Kumaraswamy; Neil S Cooch; Andrew K Godwin; Ramin Shiekhattar
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

2.  Blocking BRE expression in Leydig cells inhibits steroidogenesis by down-regulating 3beta-hydroxysteroid dehydrogenase.

Authors:  J Miao; K-W Chan; G G Chen; S-Y Chun; N-S Xia; J Y H Chan; N S Panesar
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

Review 3.  Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway.

Authors:  Erika Cretney; Kazuyoshi Takeda; Mark J Smyth
Journal:  Int J Biochem Cell Biol       Date:  2006-10-07       Impact factor: 5.085

4.  The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine.

Authors:  Angen Liu; Ken-Ichi Yoshioka; Vincenzo Salerno; Peggy Hsieh
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

Review 5.  TNF: a master switch for inflammation to cancer.

Authors:  Gautam Sethi; Bokyung Sung; Bharat B Aggarwal
Journal:  Front Biosci       Date:  2008-05-01

Review 6.  The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway.

Authors:  S Wang
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

7.  BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinoma.

Authors:  B C-L Chan; A K-K Ching; K-F To; J C-K Leung; S Chen; Q Li; P B-S Lai; N L-S Tang; P-C Shaw; J Y-H Chan; A E James; K-N Lai; P-L Lim; K K-H Lee; Y-L Chui
Journal:  Oncogene       Date:  2007-08-20       Impact factor: 9.867

8.  Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I.

Authors:  C Prigent; M S Satoh; G Daly; D E Barnes; T Lindahl
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites.

Authors:  Bijan Sobhian; Genze Shao; Dana R Lilli; Aedín C Culhane; Lisa A Moreau; Bing Xia; David M Livingston; Roger A Greenberg
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

Review 10.  Many faces of NF-kappaB signaling induced by genotoxic stress.

Authors:  Zhao-Hui Wu; Shigeki Miyamoto
Journal:  J Mol Med (Berl)       Date:  2007-07-03       Impact factor: 4.599

View more
  4 in total

1.  C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.

Authors:  A E Marneth; K H M Prange; A S A Al Hinai; S M Bergevoet; N Tesi; E M Janssen-Megens; B Kim; N Sharifi; M L Yaspo; J Kuster; M A Sanders; E C G Stoetman; J Knijnenburg; T C J M Arentsen-Peters; C M Zwaan; H G Stunnenberg; M M van den Heuvel-Eibrink; T Haferlach; M Fornerod; J H Jansen; P J M Valk; B A van der Reijden; J H A Martens
Journal:  Leukemia       Date:  2017-09-05       Impact factor: 11.528

2.  The expression and activation of ERK/MAPK pathway in human esophageal cancer cell line EC9706.

Authors:  Shu-Tao Zheng; Qi Huo; Aerziguli Tuerxun; Wen-Jing Ma; Guo-Dong Lv; Cong-Gai Huang; Qing Liu; Xing Wang; Ren-Yong Lin; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2010-05-13       Impact factor: 2.316

3.  Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.

Authors:  Erin M Siegel; Steven Eschrich; Kathryn Winter; Bridget Riggs; Anders Berglund; Abidemi Ajidahun; Jeff Simko; Jennifer Moughan; Jaffer Ajani; Anthony Magliocco; Abul Elahi; Sarah Hoffe; David Shibata
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

4.  Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative Stress.

Authors:  Hugo Ramos; Patricia Bogdanov; Joel Sampedro; Jordi Huerta; Rafael Simó; Cristina Hernández
Journal:  Antioxidants (Basel)       Date:  2020-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.